OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Alpaslan Dedeoglu

1 Projects | 1 Researchers | $148,954 Invested

2014

Boston University

Alpaslan Dedeoglu, MD, PhD

Fingolimod therapy in models of Alzheimer's disease

  • Funding Amount: $148,954
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed